Online citations, reference lists, and bibliographies.

Peritonectomy Procedures

P. Sugarbaker
Published 2003 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
ObjectiveNew surgical procedures designed to assist in the treatment of peritoneal surface malignancy were sought. BackgroundDecisions regarding the treatment of cancer depend on the anatomic location of the malignancy and the biologic aggressiveness of the disease. Some patients may have isolated intra-abdominal seeding of malignancy of limited extent or of low biologic grade. In the past, these clinical situations have been regarded as lethal. MethodsThe cytoreductive approach may require six peritonectomy procedures to resect or strip cancer from all intra-abdominal surfaces. ResultsThese are greater omentectomy-splenectomy; left upper quadrant peritonectomy; right upper quadrant peritonectomy; lesser omentectomy-cholecystectomy with stripping of the omental bursa; pelvic peritonectomy with sleeve resection of the sigmoid colon; and antrectomy. ConclusionsPeritonectomy procedures and preparation of the abdomen for early postoperative intraperitoneal chemotherapy were described. The author has used the cytoreductive approach to achieve longterm, disease-free survival in selected patients with peritoneal carcinomatosis, peritoneal sarcomatosis or mesothelioma.



This paper is referenced by
10.3978/j.issn.2078-6891.2015.115
Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.
R. N. Low (2016)
10.1111/j.1365-2044.2007.05380.x
Peri‐operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
C. Schmidt (2008)
10.5402/2011/526384
Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico
Horacio Noé López-Basave (2011)
10.1155/2012/141585
Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC
P. Sammartino (2012)
10.1186/s12957-019-1602-z
Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
Leonardo Solaini (2019)
10.1080/00015458.2016.1165019
Re-admissions for delayed complications after cytoreductive surgery and HIPEC
John D. Spiliotis (2016)
Advanced colorectal cancer: Exploring treatment boundaries
Daphne Hompes (2013)
10.18632/oncotarget.7622
Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC)
Lili Liu (2016)
10.1007/s00464-020-07712-3
Comparison of the outcomes of cytoreductive surgery versus surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: a propensity score matching analysis
Zhou Li (2020)
10.3109/07357907.2012.654871
Peritoneal Carcinomatosis: Cytoreductive Surgery and HIPEC–-Overview and Basics
B. L. Brücher (2012)
10.1245/s10434-020-08234-x
The Pathologic Peritoneal Cancer Index (PCI) Strongly Differs From the Surgical PCI in Peritoneal Metastases Arising From Various Primary Tumors
Aditi Bhatt (2020)
10.15406/JCPCR.2015.02.00057
Management of Peritoneal Metastases of Colorectal Cancer, Literature Review
Ehab Esmat Fawzy (2015)
10.1016/j.ejca.2019.10.034
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.
Rebecca C Auer (2020)
10.5230/jgc.2011.11.3.167
Clinical Outcomes according to Primary Treatment in Gastric Cancer Patients with Peritoneal Seeding
J. Bae (2011)
10.1080/02656736.2017.1368096
Identification of risk factors associated with postoperative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a retrospective study
J. Catá (2018)
10.21037/jgo.2018.01.02
Early experience with cytoreduction and hyperthermic intraperitoneal chemotherapy at a newly developed center for peritoneal malignancy.
Whitney Guerrero (2018)
10.1002/cncr.25356
Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy
O. Glehen (2010)
10.1097/COC.0b013e3181dbb9ad
Surgical Therapies in Metastatic Colorectal Cancer With a Potential for Cure
Terence C Chua (2011)
10.21037/JGO.2018.12.11
The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
R. Shamavonian (2019)
10.1186/1477-7819-11-239
Intrathoracic gastric volvulus as a severe, delayed surgical complication after left subphrenic peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian cancer
Roberto Caronna (2013)
10.1080/02656736.2019.1635717
An update of peritonectomy procedures used in cytoreductive surgery for peritoneal malignancy
Frédéric Mercier (2019)
10.1002/bjs5.50262
Repeat cytoreductive surgery with or without intraperitoneal chemotherapy for recurrent epithelial appendiceal neoplasms
J. Karpes (2020)
10.1186/1754-9493-6-12
Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients
R. Warschkow (2012)
Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
S. Asero (2009)
Hyperthermic intracavitary chemotherapy in abdomen and chest
S. V. Ruth (2003)
Measurement of serum PSA as a predictor of symptoms scored on the IPSS for patients with benign prostatic hyperplasia.
C. Jim Lim (2014)
10.2147/CMAR.S153327
Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach
Thales Paulo Batista (2017)
10.1080/1120009X.2018.1452333
Impact of tigecycline versus imipenem–cilastatin on fibrinogen levels following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study
Hakeam A. Hakeam (2018)
10.2196/resprot.7790
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study
R. T. van der Kaaij (2017)
10.1136/ejhpharm-2016-000877
Cytoreductive surgery with intraperitoneal chemotherapy in the management of peritoneal surface malignancy: a pharmacist's perspective
P. Mistry (2016)
10.5230/jgc.2014.14.4.266
The Result of Conversion Surgery in Gastric Cancer Patients with Peritoneal Seeding
S. Kim (2014)
10.1007/978-1-4614-9022-7_6
Metastatic colorectal cancer.
O. Bouché (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar